Published Online: October
| ||Format||Pages||Price|| |
|PDF Version||6||$25||  ADD TO CART|
Case illustrations are given to suggest the complexity of the effects on the quality of life of developments in psychotropic medicines, deinstitutionalization, and patients' rights. Community services often do not provide the mentally disabled with the benefits predicted for such programs. Whether the net effect of the revolutionary extrusion of the mentally disabled from public hospitals will be beneficial remains for history to judge.
Doctoral candidate in clinical psychology, University of Arizona; intern in clinical psychology, McLean Hospital, Belmont, Mass.
Assistant professor of psychiatry, Harvard Medical School, Belmont, Mass.
Stock #: JFS11313J